Skip to main content
Book cover

Nitric Oxide (NO) and Cancer

Prognosis, Prevention, and Therapy

  • Book
  • © 2010

Overview

  • the first volume to focus on studies that investigate the role of NO in tumor cell pathogenesis, growth, angiogenesis, response to cytotoxic therapies and NO translational applications in cancer therapy, alone or in conjunction with other therapies
  • Includes supplementary material: sn.pub/extras

Part of the book series: Cancer Drug Discovery and Development (CDD&D)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (25 chapters)

  1. General Overview

  2. Nitric Oxide and the Pathogenesis of Cancer

  3. Dual Roles of Nitric Oxide in Protecting or Inducing Cell Death

  4. Role of Nitric Oxide in Metastasis

  5. Nitric Oxide as a Sensitizing Agent for Chem-Radio-Immunotherapy

Keywords

About this book

Nitric Oxide (NO) is a pleitropic, ubiquitous modulator of cellular functions. Aryl nitrite and glyceryl trinitrate, representative intravasadilators, were introduced as therapeutic agents more than a century ago for relief from acute attacks of angina. The vasodilator action is mediated by the release of NO following treatment. NO has important therapeutic applications in several diseases such as inflammatory diseases, erectile dysfunction, inflammation, pain and neural protective activity. However, the role of NO in cancer and its application in therapy has received little attention. This monograph will be the first to focus on studies that investigate the role of NO in tumor cell pathogenesis, growth, angiogenesis, response to cytotoxic therapies and NO translational applications in cancer therapy, alone or in conjunction with other therapies.

Editors and Affiliations

  • Dept. Microbiology, Immunology &, Molecular Genetics, University of California, Los Angeles, Los Angeles, USA

    Benjamin Bonavida

Bibliographic Information

  • Book Title: Nitric Oxide (NO) and Cancer

  • Book Subtitle: Prognosis, Prevention, and Therapy

  • Editors: Benjamin Bonavida

  • Series Title: Cancer Drug Discovery and Development

  • DOI: https://doi.org/10.1007/978-1-4419-1432-3

  • Publisher: Humana New York, NY

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Science+Business Media, LLC 2010

  • Hardcover ISBN: 978-1-4419-1431-6Published: 17 June 2010

  • Softcover ISBN: 978-1-4614-2611-0Published: 05 September 2012

  • eBook ISBN: 978-1-4419-1432-3Published: 16 June 2010

  • Series ISSN: 2196-9906

  • Series E-ISSN: 2196-9914

  • Edition Number: 1

  • Number of Pages: X, 250

  • Topics: Cancer Research, Oncology, Pharmacology/Toxicology

Publish with us